Bayesian model of signal rewiring reveals mechanisms of gene dysregulation in acquired drug resistance in breast cancer-Reference-Cited by-同舟云学术

Bayesian model of signal rewiring reveals mechanisms of gene dysregulation in acquired drug resistance in breast cancer

Published:2017-03-13 Issue:3 Volume:12 Page:e0173331
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Azad A. K. M.,Lawen Alfons^ORCID,Keith Jonathan M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference113 articles.

1. Signal transduction and the control of gene expression;AH Brivanlou;Science,2002

2. Growth factor receptors and apoptosis regulators: signaling pathways, prognosis, chemosensitivity and treatment outcomes of breast cancer;S Sarkar;Breast Cancer (Auckl),2009

3. Mechanisms of resistance to EGFR tyrosine kinase inhibitors;L Huang;Acta Pharmaceutica Sinica B,2015

4. Signaling cross-talk in the resistance to HER family receptor targeted therapy;H Yamaguchi;Oncogene,2014

5. Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains;TJ Stuhlmiller;Cell Rep,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testing biological network motif significance with exponential random graph models;Applied Network Science;2021-11-22

2. Discovering novel cancer bio-markers in acquired lapatinib resistance using Bayesian methods;Briefings in Bioinformatics;2021-04-15

3. Globally learning gene regulatory networks based on hidden atomic regulators from transcriptomic big data;BMC Genomics;2020-10-14

4. VD-Analysis: A Dynamic Network Framework for Analyzing Disease Progressions;IEEE Access;2020

5. Targeting Oncogenic Nuclear Factor Kappa B Signaling with Redox-Active Agents for Cancer Treatment;Antioxidants & Redox Signaling;2019-03-10